FindTrial
Sign In

A study to compare effects of Dexmedetomidine and Fentanyl added to Ropivacaine in brachial plexus block

A comparative study of Dexmedetomidine and Fentanyl as adjuvants to Ropivacaine on analgesic efficacy in supraclavicular brachial plexus block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/035010
Enrollment
60
Registered
2021-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ropivacaine with Dexmedetomidine: 30 ml 0.5% Ropivacaine with 1 microgram/kg Dexmedetomidine for supraclavicular brachial plexus block Control Intervention1: Ropivacaine with Fentanyl:

Sponsors

Dr Malin Debnath
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA GRADE I AND II

Exclusion criteria

Exclusion criteria: 1. Uncooperative patients/ patients refusal 2. Patients having hypertension/ diabetes mellitus/ neuropathy/ Peripheral nerve injury 3. Geriatric/ pediatric patients 4. Pregnancy and lactation 5. Patients on anticoagulants or bleeding disorders 6. Hypersensitivity to Amide group of local anesthetic agents

Design outcomes

Primary

MeasureTime frame
Onset and duration of sensory and motor blockTimepoint: Every 2 minutes from injecting of drugs—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Rupendra Singh Thokchom

Regional Institute of Medical Sciences

penbeeru63@gmail.com9774247043

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026